Cancer Res Treat.  2016 Jul;48(3):869-882. 10.4143/crt.2015.290.

Incidence and Survival of Childhood Cancer in Korea

• Park HJ
• Moon EK
• Yoon JY
• Oh CM
• Jung KW
• Park BK
• Shin HY
• Won YJ

• KMID: 2344059
• DOI: http://doi.org/10.4143/crt.2015.290

Abstract

PURPOSE
An epidemiologic study of childhood cancer would provide useful information on cancer etiology and development of management guidelines.
MATERIALS AND METHODS
Data from the Korea National Cancer Incidence Database were used to examine the incidence and survival of cancer in patients aged 0-14 years. Patients were grouped according to the International Classification of Childhood Cancer, 3rd edition. Age-specific and age-standardized incidences per million and estimated annual percentage change (APC) were calculated by sex and age. Five-year relative survival was calculated for four periods from 1993 to 2011.
RESULTS
The study comprised 15,113 patients with malignant neoplasms. Age-standardized incidence rates for all cancers were 134.9 per million children in 1999-2011 and 144.0 and 124.9 per million for males and females, respectively (M/F ratio, 1.2; p < 0.05). The highest incidences were observed for 'leukemias, myeloproliferative diseases, and myelodysplastic diseases' (group I) (46.4), 'central nervous system neoplasms' (group III) (18.3), and 'lymphomas and reticuloendothelial neoplasms' (group II) (13.4). Age-standardized incidence increased from 117.9 in 1999 to 155.3 in 2011, with an APC of 2.4% (95% confidence interval, 2.1 to 2.7). There was a significant increase of APC in 'neuroblastoma and other peripheral nervous cell tumors' (group IV) (5.6%) and 'other malignant epithelial neoplasms and malignant melanomas' (group XI) (5.6%). The 5-year relative survival rate for all childhood cancers improved significantly from 56.2% (1993-1995) to 78.2% (2007-2011) (males, 56.7% to 77.7%; females, 55.5% to 78.8%).
CONCLUSION
This study provides reliable information on incidence and survival trends for childhood cancer in Korea.

Keyword

Neoplasms; Child; Incidence; Survival; Korea

MeSH Terms

Carcinoma
Child
Classification
Epidemiologic Studies
Female
Humans
Incidence*
Korea*
Male
Nervous System
Survival Rate

Figure

• 

  Fig. 1. Cancer incidence by diagnostic groups in children (0-14 years of age) in Korea, 1999-2011. MPD, myeloproliferative diseases; MDD, myelodysplastic diseases; CNS, central nervous system.

• 

  Fig. 2. Annual percent change of cancer incidence by diagnostic groups in children (0-14 years of age) in Korea, 1999-2011. MPD, myeloproliferative diseases; MDD, myelodysplastic diseases; CNS, central nervous system. *p < 0.05.

• 

  Fig. 3. Trends in relative survivalrate (RSR) of childhood cancerin Korea according to age and the time period, 1993-2011. (A) Both sexes. (B) Male. (C) Female.

Reference

References

1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012; 62:220–41.

2. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer. 2008; 112:416–32.

3. Michel G, von der Weid NX, Zwahlen M, Redmond S, Strippoli MP, Kuehni CE, et al. Incidence of childhood cancer in Switzerland: the Swiss Childhood Cancer Registry. Pediatr Blood Cancer. 2008; 50:46–51.

4. Baade PD, Youlden DR, Valery PC, Hassall T, Ward L, Green AC, et al. Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer. 2010; 102:620–6.

5. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–31.

6. Moreno F, Loria D, Abriata G, Terracini B; ROHA network. Childhood cancer: incidence and early deaths in Argentina, 2000-2008. Eur J Cancer. 2013; 49:465–73.

7. Mitra D, Shaw AK, Hutchings K. Trends in incidence of childhood cancer in Canada, 1992-2006. Chronic Dis Inj Can. 2012; 32:131–9.

8. Basta NO, James PW, Gomez-Pozo B, Craft AW, McNally RJ. Survival from childhood cancer in northern England, 1968-2005. Br J Cancer. 2011; 105:1402–8.

9. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005; 103:1457–67.

10. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014; 46:109–23.

11. Moon EK, Park HJ, Oh CM, Jung KW, Shin HY, Park BK, et al. Cancer incidence and survival among adolescents and young adults in Korea. PLoS One. 2014; 9:e96088.

12. Brenner H, Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol. 1997; 50:211–6.

13. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004; 23:51–64.

14. Scheurer ME, Bondy ML, Gurney JG. pidemiology of childhood cancer. In : Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins;2015. p. 2–16.

15. Bao PP, Zheng Y, Gu K, Wang CF, Wu CX, Jin F, et al. Trends in childhood cancer incidence and mortality in urban Shanghai, 1973-2005. Pediatr Blood Cancer. 2010; 54:1009–13.

16. Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011; 12:2215–20.

17. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010; 36:277–85.

18. Magrath I, Steliarova-Foucher E, Epelman S, Ribeiro RC, Harif M, Li CK, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013; 14:e104–16.

19. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64:83–103.

20. Chow EJ, Puumala SE, Mueller BA, Carozza SE, Fox EE, Horel S, et al. Childhood cancer in relation to parental race and ethnicity: a 5-state pooled analysis. Cancer. 2010; 116:3045–53.

21. Brown WM, Doll R. Leukaemia in childhood and young adult life. Br Med J. 1961; 1:981–8.

22. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H. Part I: Cancer in Indigenous Africans: burden, distribution, and trends. Lancet Oncol. 2008; 9:683–92.

23. Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer. 2008; 113:2575–96.

24. Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P. Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42:1961–71.

25. Dama E, Pastore G, Mosso ML, Maule MM, Zuccolo L, Magnani C, et al. Time trends and prognostic factors for survival from childhood cancer: a report from the Childhood Cancer Registry of Piedmont (Italy). Eur J Pediatr. 2006; 165:240–9.